Cox DA - Search Results

1

Raloxifene and estrogen inhibit neointimal thickening after balloon injury in the carotid artery of male and ovariectomized female rats.

Kauffman RF, Bean JS, Fahey KJ, Cullinan GJ, Cox DA, Bensch WR. Kauffman RF, et al. Among authors: cox da. J Cardiovasc Pharmacol. 2000 Oct;36(4):459-65. doi: 10.1097/00005344-200010000-00007. J Cardiovasc Pharmacol. 2000. PMID: 11026646

2

Comment on lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys.

Bryant HU, Kauffman RF, Iversen P, Cox DA, Mitlak BH, Heath H 3rd. Bryant HU, et al. Among authors: cox da. J Clin Endocrinol Metab. 1998 Aug;83(8):3001-4. doi: 10.1210/jc.83.8.3001-a. J Clin Endocrinol Metab. 1998. PMID: 9709984 No abstract available.

3

Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats.

Pávó I, László F, Morschl E, Nemcsik J, Berkó A, Cox DA, László FA. Pávó I, et al. Among authors: cox da. Eur J Pharmacol. 2000 Dec 20;410(1):101-4. doi: 10.1016/s0014-2999(00)00865-7. Eur J Pharmacol. 2000. PMID: 11134661

4

Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.

Anderson PW, Cox DA, Sashegyi A, Paul S, Silfen SL, Walsh BW. Anderson PW, et al. Among authors: cox da. Maturitas. 2001 Jul 25;39(1):71-7. doi: 10.1016/s0378-5122(00)00224-3. Maturitas. 2001. PMID: 11451623 Clinical Trial.

5

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.

Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH. Nickelsen T, et al. Among authors: cox da. Psychoneuroendocrinology. 1999 Jan;24(1):115-28. doi: 10.1016/s0306-4530(98)00041-9. Psychoneuroendocrinology. 1999. PMID: 10098223 Clinical Trial.

6

Raloxifene therapy.

Heath H 3rd, Cox DA, Plouffe L Jr. Heath H 3rd, et al. Among authors: cox da. J Am Geriatr Soc. 2000 Sep;48(9):1170-2. doi: 10.1111/j.1532-5415.2000.tb04801.x. J Am Geriatr Soc. 2000. PMID: 10983924 No abstract available.

7

The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.

Walsh BW, Paul S, Wild RA, Dean RA, Tracy RP, Cox DA, Anderson PW. Walsh BW, et al. Among authors: cox da. J Clin Endocrinol Metab. 2000 Jan;85(1):214-8. doi: 10.1210/jcem.85.1.6326. J Clin Endocrinol Metab. 2000. PMID: 10634389 Clinical Trial.

8

Cognitive function in postmenopausal women treated with raloxifene.

Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T; Multiple Outcomes of Raloxifene Evaluation Investigators. Yaffe K, et al. Among authors: cox da. N Engl J Med. 2001 Apr 19;344(16):1207-13. doi: 10.1056/NEJM200104193441604. N Engl J Med. 2001. PMID: 11309635 Free article. Clinical Trial.

9

Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene.

Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW. Barrett-Connor E, et al. Among authors: cox da. J Womens Health. 1998 Sep;7(7):839-47. doi: 10.1089/jwh.1998.7.839. J Womens Health. 1998. PMID: 9785310 Review.

10

Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.

Mosca L, Harper K, Sarkar S, O'Gorman J, Anderson PW, Cox DA, Barrett-Connor E. Mosca L, et al. Among authors: cox da. Clin Ther. 2001 Sep;23(9):1552-65. doi: 10.1016/s0149-2918(01)80127-2. Clin Ther. 2001. PMID: 11589267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters